Appetite disorder and Paranasal sinus hypersecretion
Paranasal sinus hypersecretion is reported only by a few people with Appetite disorder.
The study analyzes which people have Paranasal sinus hypersecretion with Appetite disorder. It is created by eHealthMe based on 1 person who has Paranasal sinus hypersecretion and Appetite disorder from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who has Appetite Disorder and Paranasal Sinus Hypersecretion is studied.
What is Appetite disorder?
Appetite disorder (abnormal eating habits) is found to be associated with 995 drugs and 623 conditions by eHealthMe.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 703 drugs and 386 conditions by eHealthMe.
Number of Paranasal sinus hypersecretion in Appetite disorder reports submitted per year:
Gender of people who have Appetite Disorder and experienced Paranasal Sinus Hypersecretion *:
- female: 100 %
- male: 0.0 %
Age of people who have Appetite Disorder and experienced Paranasal Sinus Hypersecretion *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common co-existing conditions for these people *:
- Stress And Anxiety: 1 person, 100.00%
- Pulmonary Mycosis (lung infection caused by yeast-like fungi): 1 person, 100.00%
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 1 person, 100.00%
- Memory Loss: 1 person, 100.00%
- Laxative Supportive Care: 1 person, 100.00%
- Dementia (madness): 1 person, 100.00%
- Abdominal Discomfort: 1 person, 100.00%
Common drugs taken by these people *:
- Vfend: 1 person, 100.00%
- Pepcid: 1 person, 100.00%
- Claritin: 1 person, 100.00%
- Aricept: 1 person, 100.00%
Common symptoms for these people *:
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 100.00%
- Cardiac Failure Congestive: 1 person, 100.00%
- Abdominal Discomfort: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (703 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (386 conditions)
How the study uses the data?
The study is based on Paranasal sinus hypersecretion and Appetite disorder, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Imodium and Hctz drug interaction - 2 seconds ago
- Probiotic and Rhabdomyolysis - 4 seconds ago
- Intelence and Emtriva drug interaction - 9 seconds ago
- Abilify and Taciturnity - 11 seconds ago
- Ketoprofen and Cerebral Haematoma - 11 seconds ago
- Veramyst and Pruritus Generalised - 12 seconds ago
- Atarax and Delayed Recovery From Anaesthesia - 13 seconds ago
- Crestor and Blood Creatine Abnormal - 18 seconds ago
- Soliris and Pilonidal Cyst - 21 seconds ago
- Muscle Weakness Aggravated and pfizer biontech covid vaccine - 22 seconds ago